Patents by Inventor John Edward Norris Morten

John Edward Norris Morten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds
    Publication number: 20040171004
    Abstract: This invention relates to polymorphisms in the human SLC10A2 gene and corresponding novel allelic polypeptides encoded thereby. The invention also relates to methods and materials for analysing allelic variation in the SLC10A2 gene, and to the use of SLC10A2 polymorphism in treatment of diseases with SLC10A2 drugs.
    Type: Application
    Filed: April 9, 2004
    Publication date: September 2, 2004
    Inventor: John Edward Norris Morten
  • Chemical compounds
    Publication number: 20040137503
    Abstract: This invention relates to polymorphisms in the human P2X7 gene and corresponding novel allelic polypeptides encoded thereby. The invention also relates to methods and materials for analysing allelic variation in the P2X7 gene, and to the use of P2X7 polymorphism in treatment of diseases with P2X7 drugs.
    Type: Application
    Filed: January 29, 2004
    Publication date: July 15, 2004
    Applicant: AstraZeneca AB, a Swedish Corporation
    Inventor: John Edward Norris Morten
  • Methods for analyzing LTC4 synthase polymorphisms and diagnostic use
    Publication number: 20030077592
    Abstract: This invention relates to single nucleotide polymorphisms in the LTC4 synthase gene, EMBL accession no. U50136, particularly at one or more of positions 375, 815, 1003, 2169 and 2742. The invention also relates to methods and materials for analysing allelic variation in the LTC4 synthase gene, and to the use of LTC4 synthase polymorphism in the diagnosis and treatment of leukotriene mediated diseases such as asthma and allergic rhinitis.
    Type: Application
    Filed: October 31, 2001
    Publication date: April 24, 2003
    Applicant: ZENECA LIMITED
    Inventor: John Edward Norris Morten
  • Chemical compounds
    Publication number: 20030008293
    Abstract: This invention relates to polymorphisms in the human P2X7 gene and corresponding novel allelic polypeptides encoded thereby. The invention also relates to methods and materials for analyzing allelic variation in the P2X7 gene, and to the use of P2X7 polymorphism in treatment of diseases with P2X7 drugs.
    Type: Application
    Filed: October 16, 2001
    Publication date: January 9, 2003
    Inventor: John Edward Norris Morten
  • Methods for analyzing LTC4 synthase polymorphisms and diagnostic use
    Patent number: 6316196
    Abstract: This invention relates to single nucleotide polymorphisms in the LTC4 synthase gene, EMBL accession no. U50136, particularly at one or more of positions 375, 815, 1003, 2169 and 2742. The invention also relates to methods and materials for analyzing allelic variation in the LTC4 synthase gene, and to the use of LTC4 synthase polymorphism in tie diagnosis and treatment of leukotriene mediated diseases such as asthma and allergic rhinitis.
    Type: Grant
    Filed: February 15, 2000
    Date of Patent: November 13, 2001
    Assignee: Zeneca Limited
    Inventor: John Edward Norris Morten